SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000899140-05-000047
Filing Date
2005-01-24
Accepted
2005-01-24 14:53:40
Documents
3
Group Members
STANLEY F. DRUCKENMILLER

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING ON SCHEDULE 13G d2753926b.txt SC 13G 16613
3 JOINT FILING AGREEMENT d2753926c.txt EX-99.1 1980
4 POWER OF ATTORNEY d2753926d.txt EX-99.2 2849
  Complete submission text file 0000899140-05-000047.txt   22995
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 05544145
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241
Business Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241 4128543112
DUQUESNE CAPITAL MANAGEMENT L L C (Filed by) CIK: 0001008925 (see all company filings)

IRS No.: 251772402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G